Form 4: Bluebird Bio Executive Sells Shares to Cover Tax Obligations
SEC Form 4
Richard A. Colvin, Chief Medical Officer of bluebird bio, Inc., sold 64 shares of common stock on February 3, 2025, to cover tax withholding obligations.
Summary
- Richard A. Colvin, the Chief Medical Officer of bluebird bio, Inc., reported a transaction involving the sale of company stock.
- On February 3, 2025, Colvin sold 64 shares of common stock at an average weighted price of $7.3925.
- The sale was executed to cover tax withholding obligations related to the vesting of Restricted Stock Units.
- Following the transaction, Colvin directly owns 8,194 shares of bluebird bio, Inc.
- The reporting person has granted power of attorney to Andrew Obenshain, Joseph Vittiglio, and Sydney Gaylin to execute filings on their behalf.
Sentiment
Score: 5
Explanation: This is a neutral transaction related to tax obligations, so the sentiment is neither positive nor negative.
Industry Context
This is a routine Form 4 filing, which is common for corporate executives who sell shares of their company's stock. It is a normal part of executive compensation and financial planning.
Stakeholder Impact
- The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to be significant given the small number of shares involved.
Key Dates
| Date | Description |
|---|---|
| 2024-09-23 | Date of execution of Power of Attorney. |
| 2025-02-03 | Date of stock sale transaction. |
| 2025-02-05 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.